The role of the allograft in the induction of donor-specific T cell hyporesponsiveness

被引:42
|
作者
Baker, RJ [1 ]
Hernandez-Fuentes, MP [1 ]
Brookes, PA [1 ]
Chaudhry, AN [1 ]
Lechler, RI [1 ]
机构
[1] Imperial Coll Sch Med, Hammersmith Hosp, Dept Immunol,Dept Renal Med, Div Med, London W12 0NN, England
关键词
D O I
10.1097/00007890-200108150-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. With adequate immunosuppression the majority of renal allografts are accepted, despite the exceptional vigour of the T cell alloimmune response. Previous work from this laboratory has demonstrated that this is accompanied by significant reductions in the precursor frequencies of anti-donor T cells. We have also shown that parenchymal cells are tolerogenic in vitro. We propose that the reduction in T cell frequencies may be due to the interaction between circulating T cells and potentially tolerogenic graft parenchymal cells. Primed/memory T cells (CD45RO(+)) are the only subset capable of reaching the allograft and therefore we would predict that T cell hyporesponsiveness would develop predominantly in the CD45RO(+) subset due to their trafficking properties. Methods. Frequencies of IL-2 secreting CD45RA(+) and CD45RO(+) CD4(+) T cells in response to donor and third party stimulator cells were estimated in a series of renal transplant recipients, both before and after transplantation. Results. There were highly significant reductions in the frequencies of donor-specific CD4(+)CD45RO(+) T cells, when adjusted to control for the generalised effects of immunosuppression. There were no significant alterations in the frequencies of donor-specific CD4(+)CD45RA(+) T cells. Conclusions. In renal transplant recipients, donor-specific CD4(+) T cell hyporesponsiveness occurs predominantly in CD4(+) CD45RO(+) T cells which is the subset capable of trafficking through the graft.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 50 条
  • [21] Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
    Min, WP
    Gorczynski, R
    Huang, XY
    Kushida, M
    Kim, P
    Obataki, M
    Lei, J
    Suri, RM
    Cattral, MS
    JOURNAL OF IMMUNOLOGY, 2000, 164 (01): : 161 - 167
  • [22] CLINICAL-SIGNIFICANCE OF IN-VITRO DONOR-SPECIFIC HYPORESPONSIVENESS IN RENAL-ALLOGRAFT RECIPIENTS AS DEMONSTRATED BY THE MLR
    GHOBRIAL, II
    MORRIS, AG
    BOOTH, LJ
    TRANSPLANT INTERNATIONAL, 1994, 7 (06) : 420 - 427
  • [23] Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells
    Sugiura, K
    Kato, K
    Hashimoto, F
    Jin, T
    Amoh, Y
    Yamamoto, Y
    Morita, H
    Okumura, K
    Ikehara, S
    IMMUNOBIOLOGY, 1997, 197 (05) : 460 - 477
  • [24] Induction of Regulatory T-cells by Donor-Specific Blood Transfusion in the Absence of Presence of Liver Allograft Transplantation
    Grisham, Matthew B.
    Abe, Yuta
    Ostanin, Dmitry V.
    Zibari, Gazi
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [25] Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients
    Ng, WF
    Hernandez-Fuentes, M
    Baker, R
    Chaudhry, A
    Lechler, RI
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (12): : 2983 - 2989
  • [26] THE INDUCTION OF IMMUNOLOGICAL HYPORESPONSIVENESS BY PREOPERATIVE DONOR-SPECIFIC TRANSFUSIONS AND CYCLOSPORINE IN HUMAN CADAVERIC TRANSPLANTS - A PRELIMINARY TRIAL
    ALEXANDER, JW
    BABCOCK, GF
    FIRST, MR
    DAVIES, CB
    MADDEN, RL
    MUNDA, R
    PENN, I
    FIDLER, JP
    COFER, BR
    STEPHENS, G
    SCHROEDER, TJ
    HARIHARAN, S
    CARDI, M
    MANZLER, A
    COHEN, L
    MENDOZA, N
    CLYNE, D
    GIESE, F
    TRANSPLANTATION, 1992, 53 (02) : 423 - 427
  • [27] Donor-specific transfusion and renal allograft outcome
    Lezaic, V
    Jovicic, S
    Simic, S
    Blagojevic, R
    Stolic, I
    Simonovic, R
    Djukanovic, L
    NEPHRON, 2002, 92 (01) : 246 - 247
  • [28] Induction of Donor-Specific T-Cell Hyporesponsiveness Using Dexamethasone-Treated Dendritic Cells in Two Fully Mismatched Rat Kidney Transplantation Models
    Stax, Annelein M.
    Gelderman, Kyra A.
    Schlagwein, Nicole
    Essers, Maria C.
    Kamerling, Sylvia W. A.
    Woltman, Andrea M.
    van Kooten, Cees
    TRANSPLANTATION, 2008, 86 (09) : 1275 - 1282
  • [29] Induction of donor-specific tolerance by bone marrow infusion in organ allograft recipients.
    Salgar, SK
    Shapiro, R
    Corry, R
    Dodson, F
    Pham, S
    Zeevi, A
    Keenan, R
    Jordan, M
    Abu-Elmagd, K
    Griffith, B
    Starzl, TE
    Fung, JJ
    Rao, AS
    FASEB JOURNAL, 1999, 13 (05): : A1129 - A1129
  • [30] Role of ICAM-1 in the induction of antigen-specific T cell hyporesponsiveness.
    Chung, SW
    Gould, B
    Gorczynski, RM
    FASEB JOURNAL, 1996, 10 (03): : 3995 - 3995